Introduction {#s1}
============

Invasive pneumococcal disease (IPD) caused by *Streptococcus pneumoniae* has decreased significantly after implementation of the pneumococcal conjugate vaccine (PCV) (Pilishvili et al., [@B43]; Tocheva et al., [@B55]). However, nasopharyngeal carriage of the pneumococcus in children \<5 years old appears to continue at roughly 20--30% of the population in the US or Europe (Weatherholtz et al., [@B59]; Sharma et al., [@B52]; Fleming-Dutra et al., [@B16]; Lee et al., [@B32]). Carriage in low and middle income countries is higher with a pooled average of \~65% (Adegbola et al., [@B2]) and up to 75% in South Africa (Nzenze et al., [@B39]). Results from epidemiologic surveys show that the incidence of capsular serotypes targeted by the vaccine (VT) has decreased, while non-VT serotypes have increased (Huang et al., [@B23]; Pelton et al., [@B41]; Sharma et al., [@B52]). In particular, evidence is emerging that the serotypes targeted in the current vaccines include a lower fraction of the serotypes causing IPD in young children particularly in Asia and Africa compared to the protection afforded young children by the vaccines in developed countries (Hausdorff et al., [@B19]).

Detection of *S. pneumoniae* in clinical samples has traditionally been performed using microbiological cultures (Reller et al., [@B46]) or more recently, by quantitative PCR targeting the autolysin (*lytA)* gene (Messmer et al., [@B36]; WHO and CDC, [@B58]). In addition to detection of the organism from clinical samples, it is important to characterize the capsular serotype, since it has been shown that VT isolates are more likely to cause invasive disease than non-VT isolates (Weatherholtz et al., [@B59]; Fleming-Dutra et al., [@B16]). Capsule type is determined by serology using standardized antisera (Reller et al., [@B46]) or by multiplex PCR approaches that are able to discriminate between 20 and 37 of the more than 90 known capsule types (Satzke et al., [@B48]). However, these methods are laborious and expensive, and they have the inherent shortcoming that they cannot easily detect several capsular types in a single sample (Satzke et al., [@B48]). Methods that use high-throughput DNA sequencing have been presented as alternatives for capsular typing (Leung et al., [@B33]; Ip et al., [@B24]). These methods have relied on using a PCR enrichment step where the capsule loci are preferentially amplified directly from clinical samples, and thus suffer from similar limitations as multiplex PCR strategies. A more recent typing scheme using reads from whole genome sequence (WGS) data was developed to assign an *in silico* serotype (Kapatai et al., [@B29]). Here, we expand on the WGS approach using whole-metagenome sequencing of *Streptococcus*-enriched cultures and simultaneous development of bioinformatics approaches that clearly identify the capsular type. Our study demonstrates that metagenomics methods for serotyping *S. pneumoniae* directly from infant samples provide the potential for determining capsule information, the presence of other NP colonizers, and for providing data relating to virulence and drug resistance carriage.

Materials and methods {#s2}
=====================

Study design and subjects
-------------------------

This study was performed in healthy infants whose mothers delivered at the Research Institute of Tropical medicine associated clinic in Muntinlupa City, Philippines or Chris Hani Baragwanath Hospital in Johannesburg, South Africa between June 2012 and January 2013. All mothers attending the clinics during the recruitment periods at each location were invited to participate in the study and written consent was obtained from all who agreed to participate. The study was approved by the Ethics Committees at both clinical sites and at the J. Craig Venter Institute (JCVI). Children were recruited to participate for 12 months. All of the children in South Africa were vaccinated against pneumococcus using PCV-7 according to the national vaccination schedule (Madhi et al., [@B35]). The Philippines had not implemented a national vaccination program against pneumococcus so half the children were randomly assigned to receive the PCV-10 vaccine (Rodenburg et al., [@B47]) vaccine.

Nasopharyngeal sample collection and enrichment protocol
--------------------------------------------------------

Sampling was performed according to each infant\'s scheduled visits: at birth (within 6 h), at the time of their first PCV vaccination (usually 6 weeks old), at the time of their second dose (usually at 14 weeks old), at the time of the last dose (40 weeks old), and at 12 months. Maternal samples were obtained at birth (only South Africa) and at 12 months (both sites). NP samples from infants and mothers were collected by pediatricians in the clinics using Copan Eswabs following manufacturer\'s instructions. After collection, samples were placed in 1 ml liquid Aimes buffer and stored on ice until delivery to the clinical laboratory. A 200 μl aliquot of NP sample was transferred to 6 ml Supplemented Todd-Hewitt Broth (THB) containing 0.5% yeast extract and 17% rabbit (Philippines) or fetal bovine (South Africa) serum and 10 mg/ml colistin and incubated at 37 °C at 5% CO~2~ without shaking for 6 h. Cells were then centrifuged at 9,000 rpm for 10 min and frozen at −20 C. Metagenomic DNA was extracted from this pellet using Qiagen DNeasy Blood and Tissue kit (Qiagen) following manufacturer\'s instructions. Purified DNA was transferred to QIAsafe DNA tubes (Qiagen), allowed to dry uncovered for 10--12 h in a laminar flow hood, and shipped to JCVI at ambient temperature.

Definition of carriage by *lytA* Pcr
------------------------------------

The presence of *S. pneumoniae* was assessed using a *lytA* qPCR as described (WHO and CDC, [@B58]) using primers F373: 5′-ACGCAATCTAGCAGATGAAGCA-3′ and R424: 5′ TCGTGCGTTTTAATTCCAGCT-3′. DNA was amplified using the following program: 95°C for 10 min, followed by 95°C for 15 s, 60°C for 1 min using TaqMan Universal Master Mix on a Biorad CFX96 Real-Rime PCR machine (RITM) or Applied Biosystems 7500 Real-Time PCR system(RMPRU). Samples were considered *lytA*-positive if the C~t~ value was below 35 (WHO and CDC, [@B58]).

Metagenomic DNA sequencing
--------------------------

Only a subset of *lytA*-positive samples was selected for metagenomic sequencing, where infants were sampled at random with the goals to obtain *lytA-*positive samples for each representative age and following the pneumococcal population in a subset of infants for the duration of the study. Genomic DNA sequencing libraries were generated using standard library construction (Illumina), adding sample specific barcodes. Sequencing was performed by pooling 8--22 samples in a single 2 × 250 or 2 × 300 MiSeq run to obtain \~35 million reads per run.

Metagenomic assembly pipeline
-----------------------------

A pipeline to assemble reads and evaluate assembly content was developed as follows: (1) reads were adaptor and quality trimmed using trimmomatic (Bolger et al., [@B6]); (2) reads that mapped to the human reference genome GRCh38 (GCA_000001405.15) using bowtie2 version 2.2.7 (Langmead and Salzberg, [@B31]) with "sensitive" settings were removed; (3) filtered reads were then assembled with metaSPAdes version 3.7.1 (arXiv:1604.03071); and (4) BLAST-based evaluation of taxonomic and serotype content (details below) was conducted across metaSPAdes assembled contigs.

Assembly-based and read-based taxonomic analysis
------------------------------------------------

In order of execution, contigs larger than 200 bp from each metagenomic assembly were aligned against (1) a database of common Streptococcus genomes to identify intended host targets (alignments greater than 95% identity); and (2) the human reference GRCh38 to remove ancillary human contigs (alignments greater than 90% identity). Finally, the remaining set of contigs were aligned to the NCBI NT Bacterial Database (ref, link) BLASTN matches with \>97% identity over 5% of the contig length were considered a match. The filtered BLASTN output from each sample were combined and then queried to identify the predominant taxa present in the enrichments by compiling all of the occurrences of a given reference genome across the samples. This genome list was then used to build a reference nucleotide database for read-mapping to more quantitatively assess the relative abundance of each taxa in the enrichment samples (Table [S1](#SM1){ref-type="supplementary-material"}). The database also included all finished *S. pneumoniae* genomes. Metagenomic reads were mapped using bowtie2 with very-sensitive settings such that reads could only map once to the reference taxonomic database. Counts of mapped reads to each genome were quantified and were used to assess the relative abundance in different samples.

16S rRNA community analysis of the non-enriched NP microbiome
-------------------------------------------------------------

To determine the pre-enrichment NP bacterial community composition, 16S rRNA amplicon profiling was performed on the initial sample before the enrichment step. Operational taxonomic units (OTUs) were generated *de novo* from raw Illumina sequence reads using an *in-house* analyses pipleline relying on the UPARSE (Edgar, [@B14]) and mothur (Schloss et al., [@B49]) open-source bioinformatics tools. Briefly, paired-end reads were trimmed of adapter sequences, barcodes, and primers prior to assembly, followed by discarding low quality reads and singletons. After a de-replication step and abundance determination, sequences were filtered for chimeras and clustered into OTUs. To assign taxonomy, we used the Wang classifier, and bootstrapped using 100 iterations. We set mothur to report full taxonomies only for sequences where 80 or more of the 100 iterations were the identical (cutoff = 80). Taxonomies were then assigned to the OTUs with mothur using version SSU Ref NR 99 version of the SILVA 16S ribosomal RNA database (Quast et al., [@B45]) as the reference. Tables with OTUs and the corresponding taxonomy assignments were generated and used in subsequent analyses. The resulting matrices were summarized by frequency across species-level resolution.

Assembly-based *in silico* capsular and multi-locus sequence typing
-------------------------------------------------------------------

The first step for establishing *in silico* method for serotyping was to create a nucleotide database of serotype sequences. Serotypes were assumed to be predominantly driven by the capsule polysaccharide (*cps*) locus of the *Streptococcus* strains. Capsule sequence exemplars were retrieved for all known serotypes from Bentley et al. ([@B3]) and Skov Sorensen et al. ([@B54]). Assemblies were aligned to this reference serotype nucleotide database for *in silico* serotyping using BLASTn. Sequence alignments greater than 98% identity over 2,000 bp were kept, and top matches of the cumulative alignment length for each serotype were identified via manual curation because in some cases multiple top matches were identified when more than one serotype was present. This was evident by cases in which different contigs had top matches to different serotypes. If no match was identified, metagenomic assemblies were then queried with *aliA* (NP_357921.1) and *dexB* (NP_357904.1), the two conserved genes upstream and downstream of *cps* cluster. The sequence region between these two flanking genes was then extracted from each metagenome assembly and evaluated by BLAST against the nucleotide non-redundant nt/nr database at NCBI to identify the match with the top total score. Multi-locus sequence typing (MLST) was performed on each metagenomic assembly *in silico* using LOCUST (Brinkac et al., [@B7]) using the *S. pneumoniae* MLST scheme at <https://pubmlst.org/spneumoniae> (Jolley and Maiden, [@B26]).

Virulence and antibiotic resistance gene analysis
-------------------------------------------------

Contigs from metagenomic enrichment analysis were compared using BLAST alignments against a reference databases containing known antibiotic resistance determinants or virulence factors including *S. pneumoniae*-specific virulence genes (Zhou et al., [@B60]; Kadioglu et al., [@B27]; Liu and Pop, [@B34]; Mitchell and Mitchell, [@B37]; Chen et al., [@B10]; Blumental et al., [@B4]). BLAST results were filtered for hits that were greater than 90% identical over 80% of the reference length.

Results {#s3}
=======

*lytA*-positive burden in South Africa and Philippine infants
-------------------------------------------------------------

A total of 393 nasopharyngeal (NP) samples from 203 infants enrolled in our pediatric microbiome study were analyzed for *lytA* carriage as a proxy for *S. pneumoniae* colonization (Table [1](#T1){ref-type="table"}). Most samples represented the first sample immediately after birth, the 6-, and 14-, 40-week, and 12 months since these corresponded to the pediatric visits when the PCV vaccine was administered or were the end-point of the microbiome project. After culture enrichment, the proportion of *lytA*-positive samples (C~T~ \< 35) increased consistently with infant age, ranging from as low as 23.7% at birth to consistently above 85% after 7 months, with very little difference in the *lytA*-positive rates between the Philippines and South Africa, irrespective of vaccination status. Mother carriage of *lytA*-positive samples in South Africa was \~45% while *lytA* carriage from mothers in the Philippines was nearly 100%.

###### 

Summary of *lytA* tested samples.

  **Infant age**                                **Site**       **Negative**   **Positive**   **Percent Positive**
  --------------------------------------------- -------------- -------------- -------------- ----------------------
  Birth                                         Philippines    2              1              33.3
                                                South Africa   44             14             23.7
  6 weeks[^\*^](#TN1){ref-type="table-fn"}      Philippines    32             13             28.9
                                                South Africa   22             19             46.3
  3 months[^\*^](#TN1){ref-type="table-fn"}     South Africa   6              14             70
  4 months[^\*\*^](#TN2){ref-type="table-fn"}   Philippines    6                             79.3
  6 months                                      South Africa   1              4              80
  7 months                                      South Africa   7              22             95.6
  8 months                                      South Africa   2              12             86
  9 months                                      South Africa                  2              100
  10 months[^\*^](#TN1){ref-type="table-fn"}    Philippines    10             59             85.5
                                                South Africa   1              10             91
  11 months                                     South Africa   1              8              89
  12 months                                     Philippines    1              30             95.6
                                                South Africa                  14             100
  13 months                                     South Africa                  10             100
  15 months                                     South Africa   1              1              50
  Total                                                        137            256            61.5

*PCV administration in Philippines and South Africa*.

*PCV administration in Philippines*.

*Positive samples were defined as those with qPCR Ct values \< 35 cycles*.

We obtained longitudinal time points for 93 subjects ranging from 2 to 7 samples per infant (average 3 samples). Thirty-three (35%) of those infants had *lytA-*positive samples every time they were sampled, including their earliest visit (Table [1](#T1){ref-type="table"}). Of the remaining infants with longitudinal samples, 54 had negative *lytA* samples in their early visits and became *lytA-*positive over time, following the overall trend described above. The remaining six infants had negative *lytA* samples each time they were tested, though all but 2 of these samples corresponded to less than 2 months of age, again suggesting that the carriage and abundance of *lytA*-positive organisms is low at a very young age.

Metagenomic sequencing and analysis of streptococcal carriage
-------------------------------------------------------------

A total of 51 samples were selected for further characterization through metagenomic sequencing in order to identify the various strains colonizing the NP of infants in each country. Samples were selected to represent primarily infants who had the maximum number of longitudinal *lytA*-positive samples in order to determine the effect of vaccination on pneumococcal population dynamics. Twelve samples were obtained from seven South African infants and 39 samples from 25 Philippine infants. Roughly one-half of the samples belonged to longitudinal samplings (Table [2](#T2){ref-type="table"}). The majority of samples encoded multiple *lytA* genes in the metagenomic assembly of at least 80% nucleotide identity to the *S. pneumoniae* reference *lytA* sequence (NP_359346.1) (range: 1--4 copies, Table [2](#T2){ref-type="table"}).

###### 

Metagenomic enrichment sample characteristics.

                                                                          ***\# of lytA*** **(NP_359346.1) copies**   ***In silico*** **serotyping (approximate coverage)**                                  
  ------------- ---------- --------- ----------- ------ --------- ------- ------------------------------------------- ------------------------------------------------------- --- ------------ ------------- ---
  RITM002I4     RITM002    4         2,196,659   606    2324313           1                                           2                                                           23f (34x)    15a (19x)     0
  RITM003I4     RITM003    4         1,449,077   1424   4108301                                                       3                                                           23a                        0
  RITM004I4     RITM004    4         1,160,995   724    4031720                                                                                                               3   45                         2
  RITM008I4     RITM008    4         1,190,829   737    3305375                                                                                                               2   nt                         2
  RITM009I10    RITM009    10        642,274     653    3255034                                                       1                                                       2   14                         1
  RITM019I10    RITM019    10        603,977     243    2169452           1                                                                                                   1   18c                        0
  RITM020I4     RITM020    4         2,267,733   468    3708044   771     1                                           1                                                           6a                         1
  RITM020I10    RITM020    10        1,591,241   1444   4769031           1                                           1                                                       2   nt                         2
  RITM020I12    RITM020    12        1,217,954   835    3059123                                                                                                               2   nt                         1
  RITM021I10    RITM021    10        6,470,947   830    3869427   383     1                                                                                                   2   16f                        1
  RITM022I4     RITM022    4         1,113,057   718    4101518           1                                           1                                                       2   15f                        1
  RITM022I12    RITM022    12        1,358,394   724    3245844                                                       1                                                       1   nt                         1
  RITM023I4     RITM023    4         1,533,815   525    4227905           1                                           1                                                       2   6b                         0
  RITM029I10    RITM029    10        2,479,318   1000   4431671           1                                                                                                   2   5b (151x)    15b/c (50x)   1
  RITM034I10    RITM034    10        1,326,646   614    2491075           1                                                                                                   1   nt                         1
  RITM034I12    RITM034    12        1,508,905   432    4187807           1                                                                                                   1   19f                        1
  RITM038I10    RITM038    10        739,843     515    3831006           1                                           1                                                       2   19f                        1
  RITM042I10    RITM042    10        1,380,897   805    2914729           1                                                                                                   2   nt                         1
  RITM043I2     RITM043    6 weeks   3,162,069   1228   3460826           1                                           1                                                           \~6b                       0
  RITM046I2     RITM046    6 weeks   2,477,879   423    2836698                                                       1                                                           nt                         1
  RITM052I2     RITM052    6 weeks   3,110,195   641    2642259           1                                                                                                   2   nt                         2
  RITM052I4     RITM052    4         1,854,279   266    2252249   42      1                                                                                                       23a                        1
  RITM052I12    RITM052    12        452,425     641    2642259           1                                                                                                   2   23a (40x)    45 (40x)      0
  RITM053I10    RITM053    10        803,332     1498   3115520                                                       1                                                       1   nt                         1
  RITM053I12    RITM053    12        1,152,462   704    4467827           1                                           1                                                       2   6a                         1
  RITM059I10    RITM059    10        642,400     565    3376556   473     1                                                                                                       6b                         1
  RITM059I12    RITM059    12        566,500     481    3142311   473     1                                                                                                       6b                         1
  RITM060I10    RITM060    10        859,223     514    2462829   Novel   1                                                                                                   1   23f                        0
  RITM060I12    RITM060    12        474,933     1242   3707253           1                                                                                                   2   45                         0
  RITM070I10    RITM070    10        347,804     871    2742804                                                       1                                                           nt                         1
  RITM070I12    RITM070    12        521,883     730    3308305           1                                           1                                                           19a                        1
  RITM071I10    RITM071    10        1,400,393   829    4529939           1                                                                                                   2   19f                        0
  RITM071I12    RITM071    12        1,954,642   652    5186483           1                                                                                                       11f (109x)   19c (22x)     0
  RITM077I2     RITM077    6 weeks   1,670,013   553    3159554   4745    1                                                                                                       20 (103x)    19c (11x)     1
  RITM077I10    RITM077    10        2,614,423   348    3178458           1                                           1                                                       1   6a                         0
  RITM081I10    RITM081    10        1,293,683   829    4529939           1                                           1                                                           nt                         2
  RITM081I12    RITM081    12        1,205,277   578    4613175           1                                           1                                                       1   nt                         2
  RITM084I2     RITM084    6 weeks   1,523,208   729    2888646                                                                                                               1   nt                         2
  RITM089I4     RITM089    4         373,100     617    2723492           1                                                                                                   1   10a                        0
  RMPRU004I4    RMPRU004   4         1,813,223   1673   2044289           1                                                                                                       nt                         0
  RMPRU004I7    RMPRU004   10        934,919     81     2110604   9811    1                                           1                                                           nt                         1
  RMPRU008I4    RMPRU008   4         1,645,268   1202   3059009                                                                                                               3   nt                         0
  RMPRU008I7    RMPRU008   10        885,194     768    2456582                                                       1                                                       1   nt                         1
  RMPRU010I3    RMPRU010   6 weeks   8,554,212   102    2088121   10550   1                                                                                                   1   15a                        0
  RMPRU010I7    RMPRU010   10        1,733,329   1447   3206902           1                                           1                                                       1   16f                        0
  RMPRU011I4    RMPRU011   6 weeks   1,688,331   125    2100736   4088    1                                           1                                                           16f                        1
  RMPRU011I7    RMPRU011   10        2,262,503   520    2329245                                                                                                               1   nt                         0
  RMPRU011I9    RMPRU011   10        1,273,109   742    4428067           1                                           1                                                       1   16f                        1
  RMPRU022I12   RMPRU022   12        467,655     1180   639982                                                                                                                2   19c                        1
  RMPRU023I2    RMPRU023   6 weeks   677,044     460    2680898   8334    1                                                                                                       23f                        0
  RMPRU031I2    RMPRU031   6 weeks   710,789     222    2147330   5647    1                                           1                                                           13                         0

*RITM, the Philippines; RMPRU, South Africa. S. pneumoniae contigs and assembled length determined by BLAST match to S. pneumoniae reference genomes for each contig (see text for details). Multilocus sequence typing (MLST) sequence types (ST) were assigned using the PubMLST database. The number of lytA copies in each assembly is based on % identity thresholds relative to the S. pneumoniae R6 copy (NP_359346.1). Serotype assignment was generated from in silico typing of WGS metagenomic assemblies (see text for details). nt, non-typeable*.

Population structure of nasopharyngeal *Streptococcus* community
----------------------------------------------------------------

Our metagenomic approach to studying *Streptococcus* spp. colonizing the nasopharynx allowed a very detailed view of the various organisms that reside in that space. The taxonomic composition of the enriched NP microbiome based on percentage of mapped reads to various reference genomes indicated the predominance of *S. pneumoniae* in most samples (Figure [1](#F1){ref-type="fig"}, Table [S2](#SM2){ref-type="supplementary-material"}, mean: 61.6%, range: 3.7--98.4%). Other common *Streptococcus* taxa include S. mitis (mean: 14.9%), *S. pseudopneumoniae* (mean: 14.4%), *S. oralis* (mean: 1.2%). Other *Streptococcus* sp. were detected at \>5% in a limited number of infants: *S. pyogenes* (1 infant: 9.4%), *S. parasanguinis* (1 infant: 11.5%), *S. anginosus* (1 infant, 12.2%). One NP sample (RMPRU011I9) had the most diverse *Streptococcus* community comprised of four species with \>10% mapped reads, though the previous two samples from that infant were comprised of primarily *S. pneumoniae* and *S. mitis* and *S. pseudopneumoniae*. Other taxa present in the enrichments include *Staphylococcus aureus* (4 samples \>5% reads, range: 0--96%), *Gemella haemolytica* (5 samples \>5%, range: 0--12.8%), and *Neisseria lactamica* (1 sample \>5%, range: 0--7.2%). The diverse *Streptococcus* sample (RMPRU011I9) also had a substantial number of *Gemella* reads in stark contrast to the previous two samples from the infant.

![Relative abundance of NP microbiome taxa from metagenomic analysis of enrichment cultures. Abundance is based on normalized read counts mapped to a reference database of *Streptoccocus* species and other taxa detected in the NP enrichment assemblies (Table [S1](#SM1){ref-type="supplementary-material"}). The sample names that indicate infant and sampling time point are provided under the x-axis. Blue lines connecting sample names highlight longitudinal samples originating from the same infant. *In silico* serotype classification was assigned using a BLAST-based strategy by aligning metagenomic assemblies against a reference database of capsule biosynthetic loci (see Methods for details). Red-colored serotype text indicates a vaccine-type serotype while a red circle depicts which vaccine-type serotype samples came from vaccinated infants. A count of the number of contigs aligning to the nonecapsulated NT_110_58-like capsule locus is given (see text for details).](fmicb-08-01661-g0001){#F1}

*Streptococcus* sp. 16S rRNA amplicon sequences comprised between \<1 and 33% of reads (Figure [2](#F2){ref-type="fig"}, Table [S3](#SM3){ref-type="supplementary-material"}) from the initial NP microbiome sample. The community composition varied greatly in relative abundance of different taxa, but the primary taxa was largely consistent with *Dolosigranulum, Haemophilus, Prevotella, and Moraxella* being the most prevalent. Other taxa prevalent in a fewer number of samples include *Porphyromonas, Finegoldia, and Johnsonella*.

![Infant nasopharyngeal microbiome taxonomic composition based on 16S rRNA amplicon sequencing of the pre-enrichment sample. Taxa with \>5% relative abundance in at least one sample are depicted.](fmicb-08-01661-g0002){#F2}

Capsular type detection and serotype prediction
-----------------------------------------------

We applied *in silico* BLAST-based methods to ascertain the capsular type(s) present in these metagenomic samples. Using a criteria of \>98% nucleotide identity, 33 samples were assigned a serotype. The most common serotype was 16f (four samples) while the following were encountered three times: 6a, 6b, 16f, 19c, 19f, and 23a (Figure [1](#F1){ref-type="fig"}, Table [2](#T2){ref-type="table"}). The presence of more than one serotype was detected in five infants. Ten samples from The Philippines cohort had capsule types belonging to PCV10 vaccine types, and five of those samples originate from vaccinated infants (i.e., RITM009, RITM059, and RITM071), most of which occurred in infants \>10 months of age. However, one VT-serotype sample originated from a 6-week-old infant (RITM043I2). One vaccinated South African infant carried a vaccine type serotype (23f) at 6 weeks, the timepoint for the first PCV7 administration. For longitudinal samples originating from the same infant, only three infants had the same capsule type at more than one visit (RITM052:23A, RITM059:6b, and RMPRU011:16f).

The samples without *in silico* serotype matches were further interrogated to determine whether nontypeable *Streptococcus* capsule biosynthetic genes were present by examining sequence content between *aliA* and *dexB*, the conserved genes flanking the capsule biosynthetic cluster. The majority of extracted capsule sequences matched at 94--96% identity to several variants of the capsule locus detailed in Park et al. ([@B40]) including the complete *S. pneumoniae* NT-110-58 genome (CP007593) (Hilty et al., [@B21]) (Table [2](#T2){ref-type="table"}), as well as the complete genomes of *S. mitis* B6 (FN568063.1) and *S. pseudopneumoniae* IS7493 (CP002925.1) (Shahinas et al., [@B50]). Similar sequences (\>94% similarity) were also present in the serotypeable samples as well (Figure [1](#F1){ref-type="fig"}) indicating that they are prevalent and co-exist with *S. pneumoniae* serotypes.

*In silico* MLST analysis
-------------------------

MLST types were definitively assigned from the metagenomes of twelve samples (Table [2](#T2){ref-type="table"}, Table [S4](#SM4){ref-type="supplementary-material"}), two of which were from the same infant (RITM059) with the same MLST type (ST473). One additional samples (RITM060I10) represented a novel sequence type comprised of previously classified alleles. South African sequence types matched other ST from South African in the PubMLST isolate database, while Philippine samples were comprised of sequence types from more diverse locations.

Virulence factors genes
-----------------------

We predicted metagenomes from *S. pneumoniae* samples to encode core virulence factors *lytA, ply* (pneumolysin), *nanA* (neuraminidase A), *hyl* (hyaluronidase), *pspC* (pneumococcal surface protein C), and *pavA* (pneumococcal adhesion and virulence A) (Hiller et al., [@B20]). All samples encoded at least one *S. pneumoniae* virulence factor when compared to reference databases (Table [S5](#SM5){ref-type="supplementary-material"}; Zhou et al., [@B60]; Chen et al., [@B10]). The five representative virulence factors examined here were present in \>50% of the metagenomes, where *ply* was present in almost all samples (98%). Several samples encoded more than one sequence distinguishable copy of *hyl, ply*, and *pavA*. One sample that contained both *S. aureus*, and *S. pyogenes* encoded a total of 62 virulence factors, including both staphylococcal and streptococcal toxins and complement evasion factors (Tables [S5](#SM5){ref-type="supplementary-material"}, [S6](#SM6){ref-type="supplementary-material"}). The majority of *Staphylococcus-*containing samples had more than 10 virulence factors including haemolysins and toxins, indicating the presence of fully virulent *S. aureus* (Powers and Wardenburg, [@B44]).

Antibiotic resistance markers
-----------------------------

Twelve samples contained antibiotic resistance genetic determinants (Table [S7](#SM7){ref-type="supplementary-material"}): nine samples from the Philippines and three from South Africa. Seven samples encoded only one antibiotic resistance marker and two samples encoded 6 or more. Metagenome assemblies from two samples encoded the *bla*(TEM-1) gene, which is the most common β-lactamase in Gram-negative bacteria (Muhammad et al., [@B38]). The gene was encoded in contigs with relatively low read coverage was highly similar to *Neisseria* plasmids (Muhammad et al., [@B38]). Both TEM-1 samples were obtained from Philippine infants, one from a 6-week visit (RITM077), and the other from the 12-month visit (RITM022). One sample from a 6-week-old infant (RMPRU023I2) encoded the methicillin-resistance gene, *mecA*. The *mecA* gene was surrounded by sequences homologous to the transponson involved in *mecA* mobilization (Katayama et al., [@B30]), suggesting it was encoded by a mobile element.

Discussion {#s4}
==========

In this study, we report the use of targeted culture enrichment and metagenomic sequencing to study the dynamics of *Streptococcus* carriage in the infant nasopharynx in the Philippines and South Africa. A total of 393 samples from 203 infants were analyzed, where the majority of early samples were *lytA*-negative which is consistent with other studies and with colonization occurring later in life (\>4 months) (Coles et al., [@B11]; Ercibengoa et al., [@B15]; Turner et al., [@B57]). Broth enrichment culture has been demonstrated to be a powerful approach to increasing the sensitivity for detecting the carriage of *S. pneumoniae* in the upper respiratory tract. When methods are compared on the same samples, the carrier fraction of the samples and the serotype diversity are maximal for the broth enrichment culture (da Gloria Carvalho et al., [@B12]). Metagenomic sequencing of the entire enrichment culture allowed us to see the range of bacteria that were selected by the enrichment culture protocol. The assembly data suggested that streptococcal enrichment was successful, with *Streptococcus* sp. reads accounting for an average of 2% of the 16S rRNA reads from the pre-enriched NP community, to an average of 93% of post-enrichment mapped reads. All samples had more than one *Streptococcus* sp. present including *S. pseudopneumoniae* and *S. mitis*. The detection of multiple *lytA* sequences of varying nucleotide similarity supports the idea that the NP community is colonized by a complex assemblage of *Streptococcus* organisms. This observation highlights the potential for genetic exchange among closely related *Streptococcus* sp. as recombination is a well-characterized mechanism for generating genetic diversity within the species (Hanage et al., [@B18]; Chaguza et al., [@B9], [@B8]). Among the other taxa identified genera by 16S rRNA gene analysis in the non-enriched primary sample, were common NP microbiome taxa including *Dolosigranulum, Haemophilus, Moraxella*, and *Prevotella* sequences (Bogaert et al., [@B5]; Perez-Losada et al., [@B42]). Some studies have suggested that *Corynebacterium* and *Dolosigranulum* presence are protective from *S. pneumoniae* colonization (de Steenhuijsen Piters and Bogaert, [@B13]), but the limited sample size and general low prevalence of *S. pneumoniae* in this 16S rRNA data precludes much inference about the relationship. Other taxa enriched in the metagenomic analysis include *Staphylococcus, Gemella*, and *Neisseria* indicating that the enrichment protocol shifted the community composition substantially.

The use of *lytA* for detecting pneumococcus in community acquired pneumonia cases has been documented and is frequently employed as a rapid assay (Abdeldaim et al., [@B1]). In this study where the subjects were largely free of respiratory infections, the *lytA* assay detected the presence of *S. pneumoniae* as a member of the commensal microbiome but also detected other *lytA* containing streptococcal species in the commensal NP microbiome. Recent screening assays have in fact documented that *lytA* is not a specific diagnostic gene for *S. pneumoniae* (Simoes et al., [@B53]). Undoubtedly the use of a second pneumococcus selective gene would greatly improve the specificity of the assay for use as a rapid pneumococcus diagnostic tool for respiratory infections.

Although the presence of *Streptococcus* spp. in the nasopharynx of these infant subjects was both common and frequent, it was relatively uncommon for a child to have consistent colonization by the same *S. pneumoniae* strain. There were only three instances of the same capsular type in samples obtained over 3 months apart. Studies of serotype switching have been focused on such switching events in the context of PCV vaccination (for example see Hanage et al., [@B17]) but not in such young children. Serotypes related to the vaccine (PCV10 in the Philippines and PCV7 in South Africa) were observed in 11 samples, seven of which came from vaccinated infants. However, two of these samples originated from infants on their first scheduled vaccine administration, while the other five samples came from infants \>10 months of age. This highlights the need for further examination of vaccine success in these populations. Multiple samples also had more than one serotype present concurrently, and many encoded both typeable and non-typeable capsule loci. This is consistent with previous studies using different methods, and again highlights the potential for genetic exchange between *Streptococcus* strains (Kamng\'ona et al., [@B28]). *In silico* MLST typing indicates that many samples were not typeable, but for those that were, only one infant had the same sequence type more than once (Table [2](#T2){ref-type="table"}). The remaining samples could not be specifically assigned to a single MLST type either because the assembly did not resolve all the loci necessary for typing especially in those cases with co-occurring *S. pneumoniae*, or because loci had no matches compared to known MLST types.

The 16S rRNA NP longitudinal sampling demonstrated consequential variation between successive samples for the NP community composition in our infants during their first year of life. It is likely that the serotype variation we are observing is a consequence of the inherent instability of the NP microbiome during this early stage of life (Jebaraj et al., [@B25]; Hohwy et al., [@B22]; Turner et al., [@B56]; Ercibengoa et al., [@B15]). Another striking observation on the NP microbiomes in these infants is the prevalence of potentially pathogenic species acting as commensal members of the young infant NP microbiome. We have noted the presence of pathogenic bacteria in the respiratory tract microbiome of lung transplant patients in the absence of an infection, and often when these patients did present with a pneumonia, the pathogen was earlier detectable as a prior member of the commensal population before the onset of disease (Shankar et al., [@B51]). In this context it is not surprising that we detected the presence of at least one *S. pneumoniae* virulence factor in all of the metagenomic enrichment culture samples, with the majority of *Staphylococcus*-containing samples exhibiting more than 10 virulence factors. Furthermore, our detection of antibiotic resistance genes and mobile elements that can be easily transferred between strains suggests that the infant NP serves as a reservoir for antibiotic resistant potential. These observations are consistent with a hypothesis that in these young infants, potentially pathogenic bacteria are common members of the commensal microbiome and that bacterial respiratory disease does not simply result from the presence of a bacterial respiratory pathogen but is the result of a more complex interaction between the host immune system status and the respiratory tract microbiome. However, the mechanisms behind the activation and phenotypic manifestation of virulence in the early NP microbiome remain unclear.

Conclusions {#s5}
===========

The *in silico* serotype approach here may contribute to serotype analysis of strains isolated from infants that could lead to better data on residual serotypes that constitute the reservoir for future pneumococcal infections post-targeted vaccines to prevent IPD in infants in these countries. In addition, the study revealed the frequent presence of bacterial pathogens in the NP microbiome of these infants with genomes encoding an abundance of virulence and antibiotic resistance elements. Evidence is emerging that the serotypes targeted in the current vaccines are not as protective for young children in developing countries. The serotype tool reported here may contribute to serotype analysis of strains isolated for infants with IPD that could lead to developing better targeted vaccines to prevent IPD in infants in these countries.
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